Information Provided By:
Fly News Breaks for February 24, 2020
PFPT, FEYE
Feb 24, 2020 | 08:11 EDT
Morgan Stanley Group Meetings at RSA Conference 2020 will be held in San Francisco on February 24-25.
News For VRNS;VMW;TUFN;PING;PFPT;NET;MIME;LUV;JNJ;GS;GM;FTNT;FEYE;CSCO;CHKP;AKAM From the Last 2 Days
NET
Apr 13, 2021 | 13:05 EDT
Bullish option flow detected in Cloudflare with 23,886 calls trading, 5x expected, and implied vol increasing over 4 points to 60.52%. Apr-21 75 calls and Apr-21 80 calls are the most active options, with total volume in those strikes near 8,500 contracts. The Put/Call Ratio is 0.10. Earnings are expected on May 6th.
JNJ
Apr 13, 2021 | 12:06 EDT
The major averages are mixed at midday, with the Dow lagging, the Nasdaq outperforming, and the S&P 500 slightly higher. The warmer CPI... To see the rest of the story go to thefly.com. See Story Here
FEYE
Apr 13, 2021 | 11:05 EDT
Bullish option flow detected in FireEye with 28,446 calls trading, 5x expected, and implied vol increasing over 5 points to 57.25%. May-21 21 calls and Apr-21 21 calls are the most active options, with total volume in those strikes near 12,800 contracts. The Put/Call Ratio is 0.10. Earnings are expected on April 27th.
JNJ
Apr 13, 2021 | 09:47 EDT
The White House said in a statement: "As FDA and CDC announced earlier today, out of an abundance of caution, they have recommended a pause in the use of the Johnson & Johnson vaccine as they review data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine. The FDA and CDC will be providing details at their briefing later this morning. This announcement will not have a significant impact on our vaccination plan: Johnson & Johnson vaccine makes up less than 5 percent of the recorded shots in arms in the United States to date. Based on actions taken by the President earlier this year, the United States has secured enough Pfizer and Moderna doses for 300 million Americans. Over the last few weeks, we have made available more than 25 million doses of Pfizer and Moderna each week, and in fact this week we will make available 28 million doses of these vaccines. This is more than enough supply to continue the current pace of vaccinations of 3 million shots per day, and meet the President's goal of 200 million shots by his 100th day in office-and continue on to reach every adult who wants to be vaccinated. We are working now with our state and federal partners to get anyone scheduled for a J&J vaccine quickly rescheduled for a Pfizer or Moderna vaccine."
JNJ
Apr 13, 2021 | 08:58 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly.  HIGHER - Novocure... To see the rest of the story go to thefly.com. See Story Here
JNJ
Apr 13, 2021 | 07:14 EDT
In a series of tweets, the FDA stated: "Today FDA and @CDCgov issued a statement regarding the Johnson & Johnson #COVID19 vaccine. We are recommending a pause in the use of this vaccine out of an abundance of caution... As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare... Treatment of this specific type of blood clot is different from the treatment that might typically be administered... CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases... Until that process is complete, we are recommending this pause. This is important to ensure that the health care provider community is aware of the potential for these adverse events and can plan due to the unique treatment required with this type of blood clot." Reference Link